US Patent 7652144 Compounds as PDE IV and TNF inhibitors
Patent 7652144 was granted and assigned to Aventis Pharma on January, 2010 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 18, 2007
Date of Patent
January 26, 2010
Patent Application Number
11764317
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7652144 Compounds as PDE IV and TNF inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
